These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2429842)

  • 1. Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma.
    Mulder NH; Sleijfer DT; Smit JM; De Vries EG; Willemse PH; Koops HS
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):879-81. PubMed ID: 2429842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.
    Mulder NH; Sleijfer DT; de Vries EG; Schraffordt Koops H; Samson MJ; Willemse PH
    J Cancer Res Clin Oncol; 1989; 115(1):93-5. PubMed ID: 2466036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
    Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A
    Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Long HJ; Green SJ
    Med Pediatr Oncol; 1986; 14(2):86-7. PubMed ID: 3713642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.
    Ringborg U; Jungnelius U; Hansson J; Strander H
    Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.
    Ringborg U; Rudenstam CM; Hansson J; Hafström L; Stenstam B; Strander H
    Med Oncol Tumor Pharmacother; 1989; 6(4):285-9. PubMed ID: 2693850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
    Young DW; Lever RS; English JS; MacKie RM
    Cancer; 1985 May; 55(9):1879-81. PubMed ID: 2579722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
    Samson MK; Haas CD; Baker LH; Cummings G
    Am J Clin Oncol; 1985 Apr; 8(2):167-71. PubMed ID: 3834791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group.
    Verschraegen CF; Kleeberg UR; Mulder J; Rumke P; Truchetet F; Czarnetzki B; Rozencweig M; Thomas D; Suciu S
    Cancer; 1988 Sep; 62(6):1061-5. PubMed ID: 3409184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermidine level as a parameter in the treatment of patients with malignant melanoma.
    Smit JM; Jurjens H; Bouman J; Bijzet J; Sleijfer DT; Woldring MG; Mulder NH
    Eur J Nucl Med; 1985; 10(5-6):276-7. PubMed ID: 2580707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
    Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
    Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma.
    Stables GI; Doherty VR; MacKie RM
    Br J Dermatol; 1992 Nov; 127(5):505-8. PubMed ID: 1281672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
    Mulder NH; van der Graaf WT; Willemse PH; Koops HS; de Vries EG; Sleijfer DT
    Br J Cancer; 1994 Oct; 70(4):681-3. PubMed ID: 7522510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1435-9. PubMed ID: 3595669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma.
    Cartei G; Ceschia T; Marsilio P; Clocchiatti L; Fasola G; Morandini G; Galletti D; Sibau A
    Tumori; 1989 Jun; 75(3):229-32. PubMed ID: 2475950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.
    Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B
    Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma.
    Verschraegen CF; Legha SS; Hersh EM; Plager C; Papadopoulos N; Burgess MA
    Eur J Cancer; 1993; 29A(5):708-11. PubMed ID: 8471328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma.
    Karlsson M; Jungnelius U; Aamdal S; Boeryd B; Carstensen J; Kågedal B; Westberg R; Wingren S
    Int J Cancer; 1996 Jan; 65(1):1-5. PubMed ID: 8543385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
    Khayat D; Avril MF; Gerard B; Bertrand P; Bizzari JP; Cour V
    Melanoma Res; 1992 Sep; 2(3):147-51. PubMed ID: 1450667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.